News & recognition

Milestones on the way to the clinic.

CorbiT is early — pre-clinical and patent-pending. Here's what's confirmed so far, and where we're headed next.

Recognition

Confirmed to date

Company

CorbiT founded as a KAIST spinout

Founded to bring portable specimen CT imaging — originating in KAIST nuclear & quantum engineering research — into the operating room.

IP

Patent filed for MarginX's shielded portable chamber design

CorbiT has applied for patent protection on its shielded portable chamber design, which lets MarginX skip a dedicated shielded room. Patent pending.

Recognition June 2026

CEO Ji-heun Seo wins the KAIST E5 Startup Grand Prize

Top honor at KAIST's E5 startup competition, recognizing CorbiT's early traction and vision for MarginX.

Grant July 2026

Selected for the KAIST Fast Prototyping Program

Awarded a prototyping grant through KAIST's startup support center to accelerate MarginX's hardware development.

Award July 2026

Grand Prize, 10th Busan Medical Hackathon

Recognized for MarginX's approach to intraoperative margin assessment at Busan's flagship medical innovation hackathon.

Competition August 2026

Advanced to the second round of Startup for All (모두의 창업)

Selected to continue in Korea's nationwide "Startup for All" (모두의 창업) competition.

Competition September 2026

Finalist, Gravity: Korea's Top Four Engineering Institutes Startup League

Selected as a finalist in the joint startup league among Korea's four leading engineering institutes.

Founding and patent-filing dates above are being finalized; 2026 award and competition dates are confirmed.

Press & updates

Nothing published yet

Check back soon

CorbiT is pre-clinical and hasn't announced press coverage, publications, or clinical results yet. This page will be updated as real milestones are reached.

Following CorbiT's progress?

Get in touch and we'll keep you posted as we hit our next milestones.